| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |